A large, randomized immunotherapy clinical trial continues to show improved overall survival and progression-free survival in advanced lung cancer patients, researchers reported at this year’s American Society for Clinical Oncology meeting. The update on the KEYNOTE-189 trial provides nearly two years data on use of the immunotherapy drug pembrolizumab in combination with platinum-based chemotherapy as a first-line treatment for metastatic non-small cell lung cancer. “The primary takeaway is that we saw continued benefit, even with...
Tag: <span>ONCOLOGY</span>
Post
Prior authorization obstacles unnecessarily delay patient access to cancer treatments, survey finds
AMERICAN SOCIETY FOR RADIATION ONCOLOGY ARLINGTON, Va., April 25, 2019 — Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists — physicians who treat cancer patients using radiation– released today by the American Society for Radiation Oncology (ASTRO). Nearly all radiation oncologists (93%) said that their patients are delayed from...
Post
Regular exercise should be part of cancer care for all patients
Including exercise or sport as part of cancer care can significantly improve symptom management, quality of life and fitness during and after treatment, French researchers have concluded in two presentations to be reported at the ESMO 2018 Congress in Munich. Even among patients at highest risk of poor quality of life, exercise can make a difference. More than 3,500 patients with cancer already participate in exercise programmes each year at over 80 cancer centers...
Post
Man against machine: AI is better than dermatologists at diagnosing skin cancer
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN) is better than experienced dermatologists at detecting skin cancer. In a study published in the leading cancer journal Annals of Oncology [1] today (Tuesday), researchers in Germany, the USA and...
- 1
- 2